Statewide cases of coronavirus and local cases of coronavirus both went up in the week ending Dec. 14.
Visited 1 times, 1 visit(s) today
U.S. and Chinese government officials knew as early as February 2020 that the emerging novel coronavirus that causes COVID-19 had already been well-adapted to humans – an early signal not only that it would spread efficiently, but also that it may not have emerged at the Wuhan wet market. Recently released chat messages indicate that
Dr. Madhavan Pisharodi, MD. (Photo: RGG/Steve Taylor) BROWNSVILLE, Texas – Dr. Madhavan A. Pisharodi is a neurosurgeon who has been practicing in the Rio Grande Valley of Texas for the last 31 years. Pisharodi has penned a book offering his solutions for the next coronavirus pandemic. It is titled “Corona: Be Not Proud,” and is
This conversation is with the authors of the chapter “Everything Is Different but Nothing Is New: The Missed Opportunity for Reform in the Wake of COVID-19” in our new co-edited book, Recentering Learning: Complexity, Resilience, and Adaptability in Higher Education (JHU Press, 2024). The book (in paper and ebook form) is available for order from
Universal Health Coverage (UHC) means everyone can access healthcare without financial hardship, but progress towards achieving this has stalled. The latest research on achieving UHC also focuses on the need for health equity, which is when everyone can attain their full health and wellbeing potential. This will require a willingness by healthcare leaders
New data show significant state and regional variations in long COVID rates, and experts think they know why. Source link
Moderna uses mRNA technology to combat COVID-19, RSV, cancer, and rare diseases. © Plexi Images/GHI/UCG—Universal Images Group/Getty Images Share price: $38.36 (mkt close, Dec. 18, 2024) Annual revenue: $5.08 bil. Earnings per share (prev. year): $-5.81 Moderna, Inc. is a biotechnology company specializing in messenger RNA (mRNA) medicines and is best known for developing one
Average life expectancy in the U.S. increased by almost a year in 2023, rebounding to a level not reached since the COVID-19 pandemic, according to figures released Thursday by the Centers for Disease Control and Prevention. U.S. average life expectancy was 78.4 years in 2023 ‒ nearly 11 months longer than in 2022 ‒ mostly
RECOVER-Adult study reveals refined thresholds and symptom categorization, advancing research into long COVID’s complexities. Study: 2024 Update of the RECOVER-Adult Long COVID Research Index. Image Credit: Branislav Nenin / Shutterstock.com The 2023 research index for adults with post-coronavirus disease 2019 (COVID-19) condition or long COVID has been updated using additional participant data from the Researching COVID